What is CONCENTRA GROUP HOLDINGS PAREN's earnings per share (EPS)?

CONCENTRA GROUP HOLDINGS PAREN (CON) reported diluted earnings per share of $1.30 for fiscal year 2025. This represents a -11.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CONCENTRA GROUP HOLDINGS PAREN Financials

CON

FY2025 annual

Revenue $2.2B +13.9% YoY

Net Income $166.4M -0.1% YoY

EPS (Diluted) $1.30 -11.0% YoY

Free Cash Flow $197.1M -6.3% YoY

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

CONCENTRA GROUP HOLDINGS PAREN (CON) reported $2.2B in revenue for fiscal year 2025, up 13.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CON FY2025 2026-05-07

Operating growth is real, but heavier leverage and reinvestment are absorbing more of each new revenue dollar.

From FY2023 to FY2025, revenue climbed while operating income also improved, yet net income edged down because interest expense surged from $221K to $109.3M; the company is earning more from its core operations while financing costs absorb much of that progress. The gap between a fairly steady operating margin and a lower net margin shows the pressure is mostly below the operating line, not a collapse in the underlying service economics.

Cash conversion still looks respectable, but it is becoming less generous: operating cash flow stayed near $274.7M in FY2024 and $279.4M in FY2025 even as revenue expanded, while capital spending rose to $82.3M. That helps explain why free-cash-flow margin sits at 9.1% in FY2025 versus 13.2% in FY2022, suggesting growth now requires more reinvestment or more balance tied up in operations.

The balance sheet is acquisition-shaped: goodwill reached $1.48B, roughly half of $2.86B in assets, while long-term debt remained $1.56B and cash was only $79.9M. A current ratio of 1.1x implies near-term obligations are covered, but liquidity depends more on steady operating cash generation than on a large cash cushion.

Financial Health Signals

Financial Health Score 57/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of CONCENTRA GROUP HOLDINGS PAREN's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

CONCENTRA GROUP HOLDINGS PAREN has an operating margin of 15.4%, meaning the company retains $15 of operating profit per $100 of revenue. This strong profitability earns a score of 87/100, reflecting efficient cost management and pricing power. This is down from 16.0% the prior year.

Growth

CONCENTRA GROUP HOLDINGS PAREN's revenue grew 13.9% year-over-year to $2.2B, a solid pace of expansion. This earns a growth score of 61/100.

Leverage

CONCENTRA GROUP HOLDINGS PAREN has elevated debt relative to equity (D/E of 3.98), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 17/100, reflecting increased financial risk.

Liquidity

CONCENTRA GROUP HOLDINGS PAREN's current ratio of 1.14 is below the typical benchmark, resulting in a score of 26/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

CONCENTRA GROUP HOLDINGS PAREN converts 9.1% of revenue into free cash flow ($197.1M). This strong cash generation earns a score of 67/100.

Returns

CONCENTRA GROUP HOLDINGS PAREN earns a strong 42.3% return on equity (ROE), meaning it generates $42 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 85/100. This is down from 60.4% the prior year.

Altman Z-Score Grey Zone

2.33

CONCENTRA GROUP HOLDINGS PAREN scores 2.33, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

CONCENTRA GROUP HOLDINGS PAREN passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.68x

For every $1 of reported earnings, CONCENTRA GROUP HOLDINGS PAREN generates $1.68 in operating cash flow ($279.4M OCF vs $166.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.06x

CONCENTRA GROUP HOLDINGS PAREN earns $3.06 in operating income for every $1 of interest expense ($334.0M vs $109.3M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.2B

YoY+13.9%

CONCENTRA GROUP HOLDINGS PAREN generated $2.2B in revenue in fiscal year 2025. This represents an increase of 13.9% from the prior year.

EBITDA

$409.8M

YoY+10.2%

CONCENTRA GROUP HOLDINGS PAREN's EBITDA was $409.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.2% from the prior year.

Net Income

$166.4M

YoY-0.1%

CONCENTRA GROUP HOLDINGS PAREN reported $166.4M in net income in fiscal year 2025. This represents a decrease of 0.1% from the prior year.

EPS (Diluted)

$1.30

YoY-11.0%

CONCENTRA GROUP HOLDINGS PAREN earned $1.30 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 11.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$197.1M

YoY-6.3%

CONCENTRA GROUP HOLDINGS PAREN generated $197.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 6.3% from the prior year.

Cash & Debt

$79.9M

YoY-56.4%

CONCENTRA GROUP HOLDINGS PAREN held $79.9M in cash against $1.6B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.25

YoY+300.0%

CONCENTRA GROUP HOLDINGS PAREN paid $0.25 per share in dividends in fiscal year 2025. This represents an increase of 300.0% from the prior year.

Shares Outstanding

129M

YoY+0.4%

CONCENTRA GROUP HOLDINGS PAREN had 129M shares outstanding in fiscal year 2025. This represents an increase of 0.4% from the prior year.

Margins & Returns

Gross Margin

28.3%

YoY+0.6pp

CONCENTRA GROUP HOLDINGS PAREN's gross margin was 28.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the prior year.

Operating Margin

15.4%

YoY-0.6pp

CONCENTRA GROUP HOLDINGS PAREN's operating margin was 15.4% in fiscal year 2025, reflecting core business profitability. This is down 0.6 percentage points from the prior year.

Net Margin

7.7%

YoY-1.1pp

CONCENTRA GROUP HOLDINGS PAREN's net profit margin was 7.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.1 percentage points from the prior year.

Return on Equity

42.3%

YoY-18.1pp

CONCENTRA GROUP HOLDINGS PAREN's ROE was 42.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 18.1 percentage points from the prior year.

Capital Allocation

Share Buybacks

$22.4M

YoY+45.6%

CONCENTRA GROUP HOLDINGS PAREN spent $22.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 45.6% from the prior year.

Capital Expenditures

$82.3M

YoY+28.0%

CONCENTRA GROUP HOLDINGS PAREN invested $82.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 28.0% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

CON Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CON annual income statement

Metric	TTM	FY25	FY24	FY23	FY22
Revenue	$2.3B	$2.2B+13.9%	$1.9B+3.4%	$1.8B+6.6%	$1.7B
Cost of Revenue	$1.6B	$1.6B+13.0%	$1.4B+3.5%	$1.3B+6.7%	$1.2B
Gross Profit	$670.6M	$613.1M+16.1%	$528.0M+3.0%	$512.4M+6.3%	$481.9M
SG&A Expenses	$215.6M	$203.3M+30.1%	$156.3M+2.8%	$152.0M+1.3%	$150.0M
Operating Income	$374.8M	$334.0M+9.6%	$304.8M+6.0%	$287.6M+11.3%	$258.5M
Interest Expense	N/A	$109.3M+129.1%	$47.7M+21490.0%	$221K-74.0%	$849K
Income Tax	$61.9M	$51.0M-14.3%	$59.5M+2.8%	$57.9M+9.9%	$52.7M
Net Income	$198.7M	$166.4M-0.1%	$166.5M-7.4%	$179.9M+7.9%	$166.7M
EPS (Diluted)	—	$1.30-11.0%	$1.46-15.6%	$1.73+8.1%	$1.60

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$606.0M+6.4%	$569.6M+5.7%	$539.1M-5.9%	$572.8M+4.0%	$550.8M+10.0%	$500.8M+7.7%	$465.0M-5.0%	$489.6M
Cost of Revenue	$413.9M+3.7%	$399.1M+0.2%	$398.4M-1.8%	$405.5M+4.2%	$389.3M+9.0%	$357.1M+3.6%	$344.9M-1.8%	$351.1M
Gross Profit	$192.1M+12.7%	$170.5M+21.1%	$140.7M-15.9%	$167.3M+3.6%	$161.5M+12.4%	$143.7M+19.5%	$120.2M-13.2%	$138.5M
SG&A Expenses	$56.7M+2.5%	$55.3M+8.9%	$50.8M-4.0%	$52.9M-0.1%	$52.9M+13.3%	$46.7M+2.7%	$45.5M+22.7%	$37.1M
Operating Income	$115.1M+20.4%	$95.6M+37.3%	$69.7M-26.3%	$94.5M+5.5%	$89.5M+11.5%	$80.3M+35.9%	$59.1M-31.5%	$86.2M
Interest Expense	N/A	$26.0M	N/A	N/A	N/A	$25.5M	N/A	N/A
Income Tax	$22.0M+27.3%	$17.3M+162.3%	$6.6M-58.7%	$16.0M+5.4%	$15.2M+14.3%	$13.3M+34.6%	$9.8M-40.0%	$16.4M
Net Income	$65.3M+29.3%	$50.5M+45.6%	$34.7M-28.1%	$48.3M+8.3%	$44.6M+14.5%	$38.9M+80.9%	$21.5M-51.5%	$44.3M
EPS (Diluted)	$0.51+30.8%	$0.39	N/A	$0.38+8.6%	$0.35+16.7%	$0.30	N/A	$0.37

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CON Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CON annual balance sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$2.9B+13.4%	$2.5B+8.0%	$2.3B+1.6%	$2.3B
Current Assets	$383.1M-12.4%	$437.2M+48.5%	$294.4M	N/A
Cash & Equivalents	$79.9M-56.4%	$183.3M+484.1%	$31.4M-16.7%	$37.7M
Accounts Receivable	$257.9M+18.5%	$217.7M+0.7%	$216.2M	N/A
Goodwill	$1.5B+19.8%	$1.2B+0.4%	$1.2B+0.3%	$1.2B
Total Liabilities	$2.4B+9.7%	$2.2B+92.2%	$1.2B-12.3%	$1.3B
Current Liabilities	$337.2M+9.8%	$307.2M+11.9%	$274.6M	N/A
Long-Term Debt	$1.6B+6.4%	$1.5B+44534.4%	$3.3M	N/A
Total Equity	$393.3M+42.7%	$275.7M-76.3%	$1.2B+18.5%	$979.3M
Retained Earnings	$146.4M+980.6%	$13.6M-98.0%	$685.3M	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$3.0B+4.2%	$2.9B+1.1%	$2.9B+0.5%	$2.8B+0.1%	$2.8B+4.1%	$2.7B+8.3%	$2.5B+1.6%	$2.5B
Current Assets	$506.5M+25.3%	$404.2M+5.5%	$383.1M+2.0%	$375.4M-5.0%	$395.2M+12.4%	$351.6M-19.6%	$437.2M+6.6%	$410.0M
Cash & Equivalents	$158.0M+156.1%	$61.7M-22.8%	$79.9M+60.0%	$49.9M-32.4%	$73.9M+41.8%	$52.1M-71.6%	$183.3M+33.9%	$136.8M
Accounts Receivable	$299.8M+1.1%	$296.5M+15.0%	$257.9M-7.6%	$279.0M+2.7%	$271.8M+5.3%	$258.1M+18.6%	$217.7M-6.2%	$232.2M
Goodwill	$1.5B0.0%	$1.5B+0.1%	$1.5B-0.2%	$1.5B+0.2%	$1.5B+2.5%	$1.4B+17.0%	$1.2B0.0%	$1.2B
Total Liabilities	$2.5B+2.8%	$2.4B-0.1%	$2.4B+0.2%	$2.4B-1.6%	$2.5B+3.2%	$2.4B+7.9%	$2.2B+2.0%	$2.2B
Current Liabilities	$367.9M+14.7%	$320.9M-4.9%	$337.2M+7.9%	$312.6M-6.7%	$335.1M+4.6%	$320.4M+4.3%	$307.2M+14.0%	$269.5M
Long-Term Debt	$1.6B-0.1%	$1.6B-0.1%	$1.6B-2.3%	$1.6B-3.1%	$1.7B+2.1%	$1.6B+10.2%	$1.5B-0.3%	$1.5B
Total Equity	$477.1M+12.3%	$424.7M+8.0%	$393.3M+2.0%	$385.5M+12.5%	$342.6M+11.6%	$307.1M+11.4%	$275.7M-0.8%	$277.8M
Retained Earnings	$244.2M+30.7%	$186.8M+27.6%	$146.4M+22.0%	$120.1M+50.4%	$79.8M+79.6%	$44.5M+228.0%	$13.6M	$0

Not reported in any period shown, so not listed: Inventory.

CON Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CON annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22
Operating Cash Flow	$335.5M	$279.4M+1.7%	$274.7M+17.2%	$234.3M-14.6%	$274.3M
Capital Expenditures	$68.1M	$82.3M+28.0%	$64.3M-1.0%	$65.0M+41.3%	$46.0M
Free Cash Flow	$267.4M	$197.1M-6.3%	$210.3M+24.2%	$169.4M-25.8%	$228.4M
Investing Cash Flow	-$69.6M	-$414.9M-482.1%	-$71.3M+5.4%	-$75.3M-30.4%	-$57.8M
Financing Cash Flow	-$181.7M	$32.1M+162.3%	-$51.5M+68.8%	-$165.3M+21.2%	-$209.9M
Dividends Paid	$32.0M	$32.1M+303.0%	$8.0M	$0	$0
Share Buybacks	N/A	$22.4M+45.6%	$15.4M	$0	$0

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$135.2M+543.3%	$21.0M-82.3%	$118.7M+95.8%	$60.6M-31.4%	$88.4M+655.4%	$11.7M-87.5%	$93.7M+42.2%	$65.9M
Capital Expenditures	$15.7M+41.3%	$11.1M-45.0%	$20.2M-4.9%	$21.2M-15.9%	$25.2M+60.3%	$15.7M-5.7%	$16.7M+10.2%	$15.1M
Free Cash Flow	$119.5M+1103.8%	$9.9M-89.9%	$98.5M+149.9%	$39.4M-37.6%	$63.2M+1665.9%	-$4.0M-105.2%	$77.0M+51.7%	$50.8M
Investing Cash Flow	-$14.2M+4.4%	-$14.8M+26.3%	-$20.1M+1.6%	-$20.5M+74.3%	-$79.5M+73.0%	-$294.7M-1666.4%	-$16.7M+1.6%	-$17.0M
Financing Cash Flow	-$24.7M-1.2%	-$24.4M+64.5%	-$68.6M-7.0%	-$64.1M-597.1%	$12.9M-91.5%	$151.9M+596.5%	-$30.6M-182.2%	$37.2M
Dividends Paid	$8.0M0.0%	$8.0M0.0%	$8.0M0.0%	$8.0M-50.1%	$16.0M	$0-100.0%	$8.0M	$0
Share Buybacks	$11.0M-26.9%	$15.0M	N/A	N/A	$0	$0-100.0%	$15.4M	N/A

CON Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CON annual financial ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	28.3%+0.6pp	27.8%-0.1pp	27.9%-0.1pp	27.9%
Operating Margin	15.4%-0.6pp	16.0%+0.4pp	15.7%+0.7pp	15.0%
Net Margin	7.7%-1.1pp	8.8%-1.0pp	9.8%+0.1pp	9.7%
Return on Equity	42.3%-18.1pp	60.4%+44.9pp	15.5%-1.5pp	17.0%
Return on Assets	5.8%-0.8pp	6.6%-1.1pp	7.7%+0.5pp	7.3%
Current Ratio	1.14-0.3x	1.42+0.4x	1.07	N/A
Debt-to-Equity	3.98-1.4x	5.33+5.3x	0.00-1.3x	1.35
FCF Margin	9.1%-2.0pp	11.1%+1.9pp	9.2%-4.0pp	13.2%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	31.7%+1.8pp	29.9%+3.8pp	26.1%-3.1pp	29.2%-0.1pp	29.3%+0.6pp	28.7%+2.8pp	25.9%-2.4pp	28.3%
Operating Margin	19.0%+2.2pp	16.8%+3.9pp	12.9%-3.6pp	16.5%+0.2pp	16.3%+0.2pp	16.0%+3.3pp	12.7%-4.9pp	17.6%
Net Margin	10.8%+1.9pp	8.9%+2.4pp	6.4%-2.0pp	8.4%+0.3pp	8.1%+0.3pp	7.8%+3.1pp	4.6%-4.4pp	9.1%
Return on Equity	13.7%+1.8pp	11.9%+3.1pp	8.8%-3.7pp	12.5%-0.5pp	13.0%+0.3pp	12.7%+4.9pp	7.8%-8.2pp	16.0%
Return on Assets	2.2%+0.4pp	1.8%+0.5pp	1.2%-0.5pp	1.7%+0.1pp	1.6%+0.1pp	1.4%+0.6pp	0.9%-0.9pp	1.8%
Current Ratio	1.38+0.1x	1.26+0.1x	1.14-0.1x	1.200.0x	1.18+0.1x	1.10-0.3x	1.42-0.1x	1.52
Debt-to-Equity	3.27-0.4x	3.68-0.3x	3.98-0.2x	4.15-0.7x	4.82-0.4x	5.27-0.1x	5.330.0x	5.30
FCF Margin	19.7%+18.0pp	1.7%-16.5pp	18.3%+11.4pp	6.9%-4.6pp	11.5%+12.3pp	-0.8%-17.4pp	16.6%+6.2pp	10.4%

Similar Companies

Surgery Partners Inc SGRY

$1.9B

Amedisys Inc AMED

$3.3B

Acadia Healthcar ACHC

$2.6B

Lifestance Health Group, Inc. LFST

$4.8B

Addus Homecare Corp ADUS

$2.3B

Where CONCENTRA GROUP HOLDINGS PAREN Ranks

Frequently Asked Questions

What is CONCENTRA GROUP HOLDINGS PAREN's annual revenue?

CONCENTRA GROUP HOLDINGS PAREN (CON) reported $2.2B in total revenue for fiscal year 2025. This represents a 13.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CONCENTRA GROUP HOLDINGS PAREN's revenue growing?

CONCENTRA GROUP HOLDINGS PAREN (CON) revenue grew by 13.9% year-over-year, from $1.9B to $2.2B in fiscal year 2025.

Is CONCENTRA GROUP HOLDINGS PAREN profitable?

Yes, CONCENTRA GROUP HOLDINGS PAREN (CON) reported a net income of $166.4M in fiscal year 2025, with a net profit margin of 7.7%.

What is CONCENTRA GROUP HOLDINGS PAREN's EBITDA?

CONCENTRA GROUP HOLDINGS PAREN (CON) had EBITDA of $409.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CONCENTRA GROUP HOLDINGS PAREN have?

As of fiscal year 2025, CONCENTRA GROUP HOLDINGS PAREN (CON) had $79.9M in cash and equivalents against $1.6B in long-term debt.

What is CONCENTRA GROUP HOLDINGS PAREN's gross margin?

CONCENTRA GROUP HOLDINGS PAREN (CON) had a gross margin of 28.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is CONCENTRA GROUP HOLDINGS PAREN's operating margin?

CONCENTRA GROUP HOLDINGS PAREN (CON) had an operating margin of 15.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is CONCENTRA GROUP HOLDINGS PAREN's net profit margin?

CONCENTRA GROUP HOLDINGS PAREN (CON) had a net profit margin of 7.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does CONCENTRA GROUP HOLDINGS PAREN pay dividends?

Yes, CONCENTRA GROUP HOLDINGS PAREN (CON) paid $0.25 per share in dividends during fiscal year 2025.

What is CONCENTRA GROUP HOLDINGS PAREN's return on equity (ROE)?

CONCENTRA GROUP HOLDINGS PAREN (CON) has a return on equity of 42.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is CONCENTRA GROUP HOLDINGS PAREN's free cash flow?

CONCENTRA GROUP HOLDINGS PAREN (CON) generated $197.1M in free cash flow during fiscal year 2025. This represents a -6.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is CONCENTRA GROUP HOLDINGS PAREN's operating cash flow?

CONCENTRA GROUP HOLDINGS PAREN (CON) generated $279.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are CONCENTRA GROUP HOLDINGS PAREN's total assets?

CONCENTRA GROUP HOLDINGS PAREN (CON) had $2.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are CONCENTRA GROUP HOLDINGS PAREN's capital expenditures?

CONCENTRA GROUP HOLDINGS PAREN (CON) invested $82.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does CONCENTRA GROUP HOLDINGS PAREN buy back shares?

Yes, CONCENTRA GROUP HOLDINGS PAREN (CON) spent $22.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does CONCENTRA GROUP HOLDINGS PAREN have outstanding?

CONCENTRA GROUP HOLDINGS PAREN (CON) had 129M shares outstanding as of fiscal year 2025.

What is CONCENTRA GROUP HOLDINGS PAREN's current ratio?

CONCENTRA GROUP HOLDINGS PAREN (CON) had a current ratio of 1.14 as of fiscal year 2025, which is considered adequate.

What is CONCENTRA GROUP HOLDINGS PAREN's debt-to-equity ratio?

CONCENTRA GROUP HOLDINGS PAREN (CON) had a debt-to-equity ratio of 3.98 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CONCENTRA GROUP HOLDINGS PAREN's return on assets (ROA)?

CONCENTRA GROUP HOLDINGS PAREN (CON) had a return on assets of 5.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is CONCENTRA GROUP HOLDINGS PAREN's Altman Z-Score?

CONCENTRA GROUP HOLDINGS PAREN (CON) has an Altman Z-Score of 2.33, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is CONCENTRA GROUP HOLDINGS PAREN's Piotroski F-Score?

CONCENTRA GROUP HOLDINGS PAREN (CON) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CONCENTRA GROUP HOLDINGS PAREN's earnings high quality?

CONCENTRA GROUP HOLDINGS PAREN (CON) has an earnings quality ratio of 1.68x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CONCENTRA GROUP HOLDINGS PAREN cover its interest payments?

CONCENTRA GROUP HOLDINGS PAREN (CON) has an interest coverage ratio of 3.06x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is CONCENTRA GROUP HOLDINGS PAREN?

CONCENTRA GROUP HOLDINGS PAREN (CON) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.